Kanae Togo

570 total citations
38 papers, 316 citations indexed

About

Kanae Togo is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Statistics and Probability. According to data from OpenAlex, Kanae Togo has authored 38 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Epidemiology and 7 papers in Statistics and Probability. Recurrent topics in Kanae Togo's work include Statistical Methods in Clinical Trials (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Kanae Togo is often cited by papers focused on Statistical Methods in Clinical Trials (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Kanae Togo collaborates with scholars based in Japan, United States and United Kingdom. Kanae Togo's co-authors include Naohiro Yonemoto, Nozomi Ebata, Lucy Abraham, Koichi Fujii, Manabu Iwasaki, John M. McLaughlin, Hideo Yasunaga, Tomonori Ishii, Ian Winburn and Takayuki Katsuno and has published in prestigious journals such as PLoS ONE, Journal of Thoracic Oncology and Alzheimer s & Dementia.

In The Last Decade

Kanae Togo

33 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kanae Togo Japan 11 70 70 61 44 43 38 316
Chaoyang Chen China 13 29 0.4× 59 0.8× 58 1.0× 63 1.4× 20 0.5× 41 397
А. П. Ребров Russia 9 41 0.6× 52 0.7× 99 1.6× 27 0.6× 178 4.1× 121 418
Pedro von Hafe Portugal 8 44 0.6× 77 1.1× 34 0.6× 41 0.9× 13 0.3× 26 328
Oscar Hou In Chou Hong Kong 13 59 0.8× 67 1.0× 23 0.4× 64 1.5× 22 0.5× 56 500
Mary Seger United States 13 53 0.8× 79 1.1× 65 1.1× 31 0.7× 16 0.4× 21 571
Efrosini Setakis United Kingdom 16 44 0.6× 123 1.8× 68 1.1× 44 1.0× 86 2.0× 29 1.0k
Daniel Crowther Canada 8 128 1.8× 26 0.4× 32 0.5× 58 1.3× 10 0.2× 13 420
D. Thakker India 8 64 0.9× 62 0.9× 40 0.7× 46 1.0× 33 0.8× 14 486
Nagwa Mohamed Egypt 11 64 0.9× 139 2.0× 40 0.7× 21 0.5× 27 0.6× 64 404
Ileana Adela Văcăroiu Romania 12 68 1.0× 55 0.8× 17 0.3× 38 0.9× 13 0.3× 42 365

Countries citing papers authored by Kanae Togo

Since Specialization
Citations

This map shows the geographic impact of Kanae Togo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanae Togo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanae Togo more than expected).

Fields of papers citing papers by Kanae Togo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanae Togo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanae Togo. The network helps show where Kanae Togo may publish in the future.

Co-authorship network of co-authors of Kanae Togo

This figure shows the co-authorship network connecting the top 25 collaborators of Kanae Togo. A scholar is included among the top collaborators of Kanae Togo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanae Togo. Kanae Togo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Minamisawa, Masatoshi, et al.. (2025). Patient Journey to Transthyretin Cardiac Amyloidosis Diagnosis　― A Japanese Claims Database Study ―. Circulation Journal. 89(4). 432–441. 1 indexed citations
2.
Andersen, Kathleen M., Kanae Togo, Kengo Tanabe, et al.. (2025). Inpatient burden of COVID-19 in Japan: A retrospective cohort study. Journal of Infection and Chemotherapy. 31(7). 102721–102721.
3.
Togo, Kanae, et al.. (2024). Impact of patient’s financial burden of COVID-19 treatment on antiviral prescription rates and clinical and economic outcomes. Expert Review of Pharmacoeconomics & Outcomes Research. 25(2). 215–225. 1 indexed citations
4.
Takizawa, Tsubasa, Takahiro Kitano, Masahiro Iijima, Kanae Togo, & Naohiro Yonemoto. (2024). Treatment patterns and characteristics of patients with migraine: results from a retrospective database study in Japan. The Journal of Headache and Pain. 25(1). 19–19. 18 indexed citations
5.
Shinjoh, Masayoshi, et al.. (2024). Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan. Expert Review of Vaccines. 23(1). 485–497. 10 indexed citations
6.
Sawaki, Masataka, et al.. (2023). Real-world treatment patterns of subsequent therapy after palbociclib in patients with advanced breast cancer in Japan. The Breast. 70. 1–7. 10 indexed citations
7.
Igarashi, Ataru, et al.. (2023). Inpatient and Outpatient Costs Associated With Respiratory Syncytial Virus in Japanese Infants and Older Adults. Future Virology. 18(10). 643–657. 7 indexed citations
8.
Ebata, Nozomi, et al.. (2023). Use of analgesics before and after total joint replacement in working-age Japanese patients with knee and hip osteoarthritis: A retrospective database study. Asia-Pacific Journal of Sports Medicine Arthroscopy Rehabilitation and Technology. 35. 1–8. 1 indexed citations
9.
Fukutake, Katsuyuki, et al.. (2023). Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B. Journal of Blood Medicine. Volume 14. 649–661.
10.
Kumamaru, Hiraku, Kanae Togo, Tomomi Kimura, et al.. (2023). Inventory of real‐world data sources in Japan: Annual survey conducted by the Japanese Society for Pharmacoepidemiology Task Force. Pharmacoepidemiology and Drug Safety. 33(1). e5680–e5680. 16 indexed citations
11.
Matsumoto, Nobuhiro, Kanae Togo, Naohiro Yonemoto, et al.. (2022). Developing Artificial Intelligence Models for Extracting Oncologic Outcomes from Japanese Electronic Health Records. Advances in Therapy. 40(3). 934–950. 9 indexed citations
12.
Togo, Kanae & Naohiro Yonemoto. (2022). Real world data and data science in medical research: present and future. Japanese Journal of Statistics and Data Science. 5(2). 769–781. 11 indexed citations
13.
14.
Ito, Kentaro, et al.. (2021). P69.01 Real-World Data of EGFR-TKI Treatment Sequence in Non-Small Cell Lung Cancer Patients in Japan. Journal of Thoracic Oncology. 16(3). S560–S561. 1 indexed citations
15.
Katsuno, Takayuki, Kanae Togo, Nozomi Ebata, et al.. (2021). Burden of Renal Events Associated with Nonsteroidal Anti-inflammatory Drugs in Patients with Osteoarthritis and Chronic Low Back Pain: A Retrospective Database Study. Pain and Therapy. 10(1). 443–455. 16 indexed citations
16.
Yatabe, Yasushi, Koichi Matsumura, Kanae Togo, et al.. (2020). Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan. JTO Clinical and Research Reports. 2(3). 100136–100136. 9 indexed citations
17.
Togo, Kanae, et al.. (2020). 1497. Epidemiology of RSV infection in Japan: A nationwide claims database analysis. Open Forum Infectious Diseases. 7(Supplement_1). S750–S751. 2 indexed citations
18.
Akazawa, Manabu, Kanae Togo, Nozomi Ebata, et al.. (2019). <p>Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study</p>. Journal of Pain Research. Volume 12. 1631–1648. 27 indexed citations
19.
Winburn, Ian, et al.. (2019). Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan. Cardiology and Therapy. 8(2). 297–316. 29 indexed citations
20.
Togo, Kanae & Manabu Iwasaki. (2013). Optimal Timing for Interim Analyses in Clinical Trials. Journal of Biopharmaceutical Statistics. 23(5). 1067–1080. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaoyang Chen Breakdown of academic impact, for papers by А. П. Ребров Breakdown of academic impact, for papers by Pedro von Hafe Breakdown of academic impact, for papers by Oscar Hou In Chou Breakdown of academic impact, for papers by Mary Seger Breakdown of academic impact, for papers by Efrosini Setakis Breakdown of academic impact, for papers by Daniel Crowther Breakdown of academic impact, for papers by D. Thakker Breakdown of academic impact, for papers by Nagwa Mohamed Breakdown of academic impact, for papers by Ileana Adela Văcăroiu
Rankless by CCL
2026